Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring

Aim: To compare in terms of glycemic variability two premixed insulins, Premixed Human Insulin 30/70 (PHI) and Biphasic Aspart 30 (BiAsp30), using Continuous Glucose Monitoring (CGM) and to estimate the correlation of Glycated Albumin (GA) and Fructosamine (FA) with CGM data. Patients-Data: A total...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Margaritidis, Charalampos, Karlafti, Eleni, Kotzakioulafi, Evangelia, Kantartzis, Konstantinos, Tziomalos, Konstantinos, Kaiafa, Georgia, Savopoulos, Christos, Didangelos, Triantafyllos
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8125752/
https://ncbi.nlm.nih.gov/pubmed/34063071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10091982
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars